GLX Analytix - Crunchbase Company Profile & Funding

Q: Where is GLX Analytix's headquarters?

GLX Analytix is located in Copenhagen, Hovedstaden, Denmark.

Q: Who invested in GLX Analytix?

GLX Analytix has 5 investors including Alzheimer's Drug Discovery Foundation And LabCorp Venture Fund.

Q: When was the last funding round for GLX Analytix?

GLX Analytix closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

GLX Analytix

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About GLX Analytix

CB Rank

309232

At GLX Analytix, we combine a new, proprietary class of blood biomarker with AI to bring personalized medicine to your healthcare.

Founded

obfuscation

Private

Venture - Series Unknown

Copenhagen, Hovedstaden, Denmark

1-10

glxanalytix.com/

Biotechnology

Health Care

Medical

Precision Medicine

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Brian Della Valle: Founder and CEO

Details

Legal Name

GLX Analytix ApS

Also Known As

GLX

Operating Status

Active

Company Type

For Profit

Founders

Brian Della Valle

About the Company

At GLX Analytix, we combine a new, proprietary class of blood biomarker with AI to bring personalized medicine to your healthcare. We envision a future where patients are diagnosed earlier, empowered to monitor themselves, and treatment plans are optimized. We aim to improve lives all over the world.

GLX Analytix is an Industrial Partner to

Harvard Medical / Wyss Diagnostic Accelerator and

Winner of Roche Future of Healthcare Award "...this approach has a clear potential to improve the lives of patients all over the world.” - Dr. Tim M. Jaeger, Global Head of Diagnostics Information Solutions, Roche

Contact Email

info@glxanalytix.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

GLX® Signature

A composite biomarker derived from blood glycocalyx components used for early diagnosis and monitoring of chronic inflammatory diseases.

Research & Development

GLX Analytix is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - GLX Analytix	2	obfuscated obfuscation	Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Alzheimer's Drug Discovery Foundation	Yes	Venture Round - GLX Analytix	Howard Fillit
Alzheimer's Drug Discovery Foundation	Yes	Venture Round - GLX Analytix	Howard Fillit
Alzheimer's Drug Discovery Foundation	Yes	Venture Round - GLX Analytix	Howard Fillit
Alzheimer's Drug Discovery Foundation	Yes	Venture Round - GLX Analytix	Howard Fillit
Alzheimer's Drug Discovery Foundation	Yes	Venture Round - GLX Analytix	Howard Fillit